Virtual Event

Advances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of our participants to cover a broad range of policy, research, and venture topics. This symposium provides an invaluable forum for interdisciplinary exchange at the forefront of drug research.

Lifetime Achievement Awardees

John Schiller, PhD

Deputy Chief, Laboratory of Cellular Oncology
National Cancer Institute

Douglas Lowy, MD

Director
National Cancer Institute

Participants

(more to come as we reconfirm participation for 2021)

Hal Barron, MD

CSO and President of R&D
GlaxoSmithKline

Robert Califf, MD

Head of Strategy and Policy
Verily Life Sciences and Google Health Divisions of Alphabet

Anthony Fauci, MD

Director
National Institute of Allergy and Infectious Diseases

Mir Imran, MS

Chairman and CEO
Rani Therapeutics

Stephen Knight, MD

President and Managing Partner
F-Prime Capital

Dean Li, MD, PhD

Senior Vice President, Discovery Sciences and Translational Medicine, Merck Research Laboratories

Joan Mannick, MD

Co-Founder and Chief Medical Officer
resTORbio

Philip Pizzo, MD

David and Susan Heckerman Professor and Professor of Microbiology and Immunology; Emeritus Dean, Stanford School of Medicine

Mark Smith, MD, MBA

Founding President & CEO, California Healthcare Foundation

Wendy Young, PhD

Senior Vice President, Small Molecule Drug Discovery
Genentech

Michael Basson, PhD

Senior Editor
Nature Medicine

Stanley Crooke, MD, PhD

President and CEO
Ionis Pharmaceuticals, Inc.

Levi Garraway, MD, PhD

Executive VP, Head of Product Development, and Chief Medical Officer
Genentech/Roche

Kathrin Jansen, PhD

Senior Vice President
Head of Vaccine Research and Development
Pfizer

Brian Kobilka, MD

Helene Irwin Fagan Chair in Cardiology
Stanford University
Nobel Prize in 2012

Fady Malik, MD, PhD, FACC, FAHA

Executive Vice President, Research and Development, Cytokinetics

Ken Mills

President and CEO
REGENXBIO

Andrew Plump, MD, PhD

CSO and CMO
Takeda

Janet Woodcock, PhD

Director of the Center for Drug Evaluation and Research (CDER)
FDA

Elias Zerhouni, MD

Former President for Global R&D, Sanofi
Former Director, NIH
Former US Presidential Science Envoy

Howard Bauchner, MD

Editor in Chief
JAMA and the JAMA Network

Jürgen Eckhardt, MD

Senior Vice President and Head of Leaps by Bayer

Anne Heatherington, PhD

Senior Vice President
Head of Data Sciences Institute
Takeda

Peter Kim, PhD

Virginia and D.K. Ludwig Professor of Biochemistry, Stanford

Roger Kornberg, PhD

Mrs. George A. Winzer Professor in Medicine
Stanford University
Nobel Prize in 2006

Mathai Mammen, MD, PhD

Global Head of Research and Development
Janssen

Michael Nedelman

Producer
CNN  

Serge Saxonov

Co-Founder and CEO
10x Genomics

Taiyin Yang, PhD

Executive Vice President, Pharmaceutical Development and Manufacturing, Gilead


For additional information, please contact Joseph C. Wu, MD, PhD, or Amanda Chase, PhD